Allianz Asset Management GmbH - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 145 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$735,616
-41.6%
12,800
-61.9%
0.00%
-50.0%
Q1 2023$1,260,000
-22.1%
33,600
-41.8%
0.00%
-33.3%
Q4 2022$1,618,015
+175.2%
57,745
+176.0%
0.00%
+200.0%
Q3 2022$588,000
-45.5%
20,924
-32.5%
0.00%0.0%
Q2 2022$1,079,000
+29.4%
31,009
+33.5%
0.00%0.0%
Q1 2022$834,000
+54.2%
23,2290.0%0.00%
Q4 2021$541,000
+1.5%
23,229
-17.1%
0.00%
Q3 2021$533,000
-5.0%
28,017
+0.8%
0.00%
Q2 2021$561,000
+10.2%
27,791
+0.1%
0.00%
Q1 2021$509,000
-34.1%
27,761
-46.6%
0.00%
-100.0%
Q1 2020$772,000
-23.3%
52,001
-0.4%
0.00%0.0%
Q4 2019$1,007,000
-1.4%
52,202
+1.4%
0.00%0.0%
Q3 2019$1,021,000
-62.4%
51,472
-60.0%
0.00%
-66.7%
Q2 2019$2,715,000
+6.0%
128,619
+2.6%
0.00%0.0%
Q1 2019$2,561,000
+2.8%
125,372
+0.2%
0.00%0.0%
Q4 2018$2,491,000
+17.2%
125,164
+13.3%
0.00%
+50.0%
Q3 2018$2,125,000
+45.1%
110,465
+15.1%
0.00%
+100.0%
Q2 2018$1,465,000
-2.2%
95,970
+20.1%
0.00%0.0%
Q1 2018$1,498,000
-4.7%
79,912
-2.2%
0.00%0.0%
Q4 2017$1,572,000
+7.5%
81,688
-0.2%
0.00%0.0%
Q3 2017$1,462,000
+0.1%
81,813
+0.1%
0.00%0.0%
Q2 2017$1,460,000
+23.3%
81,753
+0.2%
0.00%0.0%
Q1 2017$1,184,000
-21.7%
81,623
-0.5%
0.00%0.0%
Q4 2016$1,512,000
-16.7%
82,061
-14.2%
0.00%
-50.0%
Q3 2016$1,815,000
+19.7%
95,659
+1.7%
0.00%0.0%
Q2 2016$1,516,00094,0140.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders